• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Establishment and Analysis of Risk Prediction Model for Metabolic Dysfunction-Associated Fatty Liver Disease in Physical Examination Population].[体检人群中代谢功能障碍相关脂肪性肝病风险预测模型的建立与分析]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 May;54(3):591-595. doi: 10.12182/20230560109.
2
Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study.甘油三酯-葡萄糖指数与甘油三酯/高密度脂蛋白胆固醇比值在代谢相关脂肪性肝病患者中的诊断价值比较:一项回顾性横断面研究。
Lipids Health Dis. 2022 Jun 25;21(1):55. doi: 10.1186/s12944-022-01661-7.
3
Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Insulin Resistance-Related Indices in the Japanese Population.使用日本人群中与胰岛素抵抗相关的指标预测和验证代谢功能障碍相关的脂肪性肝病。
Metab Syndr Relat Disord. 2023 Nov;21(9):489-496. doi: 10.1089/met.2023.0116. Epub 2023 Oct 25.
4
Development and validation of a nomogram for predicting metabolic-associated fatty liver disease in the Chinese physical examination population.开发和验证适用于中国体检人群的预测代谢相关脂肪性肝病的列线图。
Lipids Health Dis. 2023 Jun 29;22(1):85. doi: 10.1186/s12944-023-01850-y.
5
[Application of TG/HDL-C Combined with Liver Function Indexes to Predict Metabolic-Associated Fatty Liver Disease].[甘油三酯/高密度脂蛋白胆固醇联合肝功能指标在预测代谢相关脂肪性肝病中的应用]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Sep;53(5):764-769. doi: 10.12182/20220960102.
6
Comparison of the prognostic value of a comprehensive set of predictors in identifying risk of metabolic-associated fatty liver disease among employed adults.比较一组综合预测因子在识别在职成年人代谢相关脂肪性肝病风险中的预后价值。
BMC Public Health. 2023 Mar 29;23(1):584. doi: 10.1186/s12889-023-15365-9.
7
Development and validation of a nomogram model for predicting the risk of MAFLD in the young population.用于预测年轻人群中MAFLD风险的列线图模型的开发与验证
Sci Rep. 2024 Apr 23;14(1):9376. doi: 10.1038/s41598-024-60100-y.
8
The metabolic profiles and body composition of non-obese metabolic associated fatty liver disease.非肥胖型代谢相关脂肪性肝病的代谢谱和身体组成
Front Endocrinol (Lausanne). 2024 Feb 5;15:1322563. doi: 10.3389/fendo.2024.1322563. eCollection 2024.
9
The newly proposed plasma-glycosylated hemoglobin A1c/High-Density lipoprotein cholesterol ratio serves as a simple and practical indicator for screening metabolic associated fatty liver disease: an observational study based on a physical examination population.新提出的血浆糖化血红蛋白 A1c/高密度脂蛋白胆固醇比值可作为筛查代谢相关性脂肪性肝病的简单实用指标:一项基于体检人群的观察性研究。
BMC Gastroenterol. 2024 Aug 19;24(1):274. doi: 10.1186/s12876-024-03362-0.
10
Prevalence and risk factors of metabolic-associated fatty liver disease during 2014-2018 from three cities of Liaoning Province: an epidemiological survey.2014-2018 年辽宁省三个城市代谢相关脂肪性肝病的患病率及相关危险因素:一项流行病学调查。
BMJ Open. 2022 Feb 17;12(2):e047588. doi: 10.1136/bmjopen-2020-047588.

本文引用的文献

1
Long or Irregular Menstrual Cycles and Risk of Prevalent and Incident Nonalcoholic Fatty Liver Disease.月经周期过长或不规律与非酒精性脂肪性肝病现患和发病风险的关系。
J Clin Endocrinol Metab. 2022 May 17;107(6):e2309-e2317. doi: 10.1210/clinem/dgac068.
2
Prevalence and risk factors of metabolic-associated fatty liver disease during 2014-2018 from three cities of Liaoning Province: an epidemiological survey.2014-2018 年辽宁省三个城市代谢相关脂肪性肝病的患病率及相关危险因素:一项流行病学调查。
BMJ Open. 2022 Feb 17;12(2):e047588. doi: 10.1136/bmjopen-2020-047588.
3
Triglycerides to high-density lipoprotein cholesterol ratio for diagnosing nonalcoholic fatty liver disease.三酰甘油与高密度脂蛋白胆固醇比值诊断非酒精性脂肪性肝病。
Minerva Gastroenterol (Torino). 2022 Sep;68(3):261-268. doi: 10.23736/S2724-5985.21.02818-X. Epub 2021 Apr 8.
4
The Role of Thyroid Hormones and Autoantibodies in Metabolic Dysfunction Associated Fatty Liver Disease: TgAb May Be a Potential Protective Factor.甲状腺激素和自身抗体在代谢功能障碍相关脂肪性肝病中的作用:TgAb 可能是一个潜在的保护因素。
Front Endocrinol (Lausanne). 2020 Dec 8;11:598836. doi: 10.3389/fendo.2020.598836. eCollection 2020.
5
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.亚太肝病学会代谢相关性脂肪性肝病临床诊疗指南。
Hepatol Int. 2020 Dec;14(6):889-919. doi: 10.1007/s12072-020-10094-2. Epub 2020 Oct 1.
6
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.代谢相关脂肪性肝病新定义:国际专家共识声明。
J Hepatol. 2020 Jul;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039. Epub 2020 Apr 8.
7
NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome.非酒精性脂肪性肝病与肝外合并症:多器官代谢综合征的现有证据。
Int J Environ Res Public Health. 2019 Sep 14;16(18):3415. doi: 10.3390/ijerph16183415.
8
Estrogen-related receptor γ controls sterol regulatory element-binding protein-1c expression and alcoholic fatty liver.雌激素相关受体 γ 控制固醇调节元件结合蛋白-1c 的表达和酒精性脂肪肝。
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Dec;1864(12):158521. doi: 10.1016/j.bbalip.2019.158521. Epub 2019 Aug 31.
9
Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis.基于社区的体质量指数对非酒精性脂肪性肝病进行风险分层。
J Formos Med Assoc. 2020 Jan;119(1 Pt 1):89-96. doi: 10.1016/j.jfma.2019.03.014. Epub 2019 Apr 2.
10
Triglycerides to high-density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: a cross-sectional study.三酰甘油与高密度脂蛋白胆固醇比值作为非酒精性脂肪性肝病的替代指标:一项横断面研究。
Lipids Health Dis. 2019 Feb 2;18(1):39. doi: 10.1186/s12944-019-0986-7.

[体检人群中代谢功能障碍相关脂肪性肝病风险预测模型的建立与分析]

[Establishment and Analysis of Risk Prediction Model for Metabolic Dysfunction-Associated Fatty Liver Disease in Physical Examination Population].

作者信息

Xia Bei, He He, Qin Ken, Li Shuang-Qing, An Zhen-Mei

机构信息

Department of Medical Genetics, West China Second University Hospital, Sichuan University, Chengdu 610041, China.

Key Laboratory of Birth Defects and Related Diseases of Women and Children of the Ministry of Education, Sichuan University, Chengdu 610041, China.

出版信息

Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 May;54(3):591-595. doi: 10.12182/20230560109.

DOI:10.12182/20230560109
PMID:37248589
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10475440/
Abstract

OBJECTIVE

To analyze the risk factors of metabolic dysfunction-associated fatty liver disease (MAFLD) in the physical examination population, to establish a risk prediction model for the occurrence of MAFLD, and to provide management strategies for the prevention and occurrence of the disease.

METHODS

A total of 14664 people who underwent physical examination at the Physical Examination Center, West China Hospital, Sichuan University between January 2018 and December 2021 were selected as research subjects. The subjects were divided into a MAFLD group ( =4013) and a non-MAFLD group ( =10651) according to whether they had MAFLD. The differences in biochemical indices, for example, glycolipid metabolism levels, were compared and logistic regression was conducted to analyze the risk factors for MAFLD, thereby establishing a nomogram prediction model. The prediction effect of the model was validated and evaluated with the consistency index (C-index) and the calibration curve.

RESULTS

Among the 14664 subjects who underwent physical examination, 4013 were MAFLD patients, presenting an overall prevalence of 27.37%, with significantly higher prevalence in men than that in women (38.99% vs. 10.06%, <0.001). Compared with those of the non-MAFLD group, the levels of glucose (GLU), total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C), aspartate transaminase (AST), alanine transaminase (ALT), gamma-glutamyl transpeptidase (GGT) and uric acid (UA) were increased ( <0.05), while the high density lipoprotein cholesterol (HDL-C) level was decreased ( <0.05) in the MAFLD group. The results of logistic regression analysis showed that male sex, age, body mass index, GLU, TG and hypertension were all independent risk factors of MAFLD, while HDL-C was a protective factor of MAFLD. The risk factors were used to establish a nomogram risk prediction model and the C-index and calibration curve showed that the nomogram model produced good predictive performance. The receiver operating characteristic (ROC) curve showed that the nomogram model had good predictive value for the risk of MAFLD.

CONCLUSION

We found a relatively high prevalence of MAFLD in the physical examination population, and the nomogram model established with routine physical examination screening can provide indications for the clinical screening and analysis of high-risk patients, which has an early warning effect on the high-risk population.

摘要

目的

分析体检人群中代谢功能障碍相关脂肪性肝病(MAFLD)的危险因素,建立MAFLD发生的风险预测模型,并为该病的预防和发生提供管理策略。

方法

选取2018年1月至2021年12月在四川大学华西医院体检中心接受体检的14664人作为研究对象。根据是否患有MAFLD将研究对象分为MAFLD组(n = 4013)和非MAFLD组(n = 10651)。比较糖脂代谢水平等生化指标的差异,并进行逻辑回归分析MAFLD的危险因素,从而建立列线图预测模型。采用一致性指数(C指数)和校准曲线对模型的预测效果进行验证和评估。

结果

在14664名接受体检的研究对象中,MAFLD患者有4013例,总体患病率为27.37%,男性患病率显著高于女性(38.99%对10.06%,P < 0.001)。与非MAFLD组相比,MAFLD组的血糖(GLU)、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、γ-谷氨酰转肽酶(GGT)和尿酸(UA)水平升高(P < 0.05),而高密度脂蛋白胆固醇(HDL-C)水平降低(P < 0.05)。逻辑回归分析结果显示,男性、年龄、体重指数、GLU、TG和高血压均为MAFLD的独立危险因素,而HDL-C是MAFLD的保护因素。利用这些危险因素建立列线图风险预测模型,C指数和校准曲线表明列线图模型具有良好的预测性能。受试者工作特征(ROC)曲线显示,列线图模型对MAFLD风险具有良好的预测价值。

结论

我们发现体检人群中MAFLD的患病率相对较高,通过常规体检筛查建立的列线图模型可为临床筛查和分析高危患者提供参考,对高危人群具有预警作用。